KIAA2022 is a gene with a significant role in neural development, with its associated protein being integral to proper brain function. The KIAA2022 protein is predominantly expressed in the brain, and mutations in this gene have been correlated with a range of neurodevelopmental disorders. This protein is thought to play a crucial part in synaptic function, and its precise role in neurodevelopmental processes is the subject of ongoing research. Understanding how the expression of KIAA2022 can be upregulated is of particular interest in the field of neurobiology, as this could elucidate the pathways and mechanisms that govern neural cell differentiation and maturation. Such knowledge is vital for comprehending the complex interactions within the brain that contribute to its development and function.
Exploration into the molecular activators that can induce the expression of the KIAA2022 protein has revealed a variety of chemical compounds with the potential to influence its expression. Non-peptide small molecules such as retinoic acid and forskolin have been shown to play roles in neuronal differentiation and the elevation of intracellular cAMP, respectively, which could lead to the upregulation of proteins involved in brain development, including KIAA2022. Similarly, histone deacetylase inhibitors like Trichostatin A and Valproic Acid may stimulate the expression of KIAA2022 by promoting a more transcriptionally active chromatin state. Compounds such as 5-Azacytidine, which causes DNA demethylation, Sodium Butyrate, an HDAC inhibitor, and Dexamethasone, which interacts with glucocorticoid receptors, also exemplify the diverse molecules that have been identified as potential activators of gene expression. These activators function through varied pathways, from modifying the epigenetic landscape to activating signaling cascades, all of which are crucial for gene expression dynamics. While these compounds have been identified based on their known biological actions and their potential to induce gene expression, the exact mechanisms by which they upregulate KIAA2022 remain a topic for further research. Understanding these mechanisms provides valuable insight into the governing principles of gene expression in the nervous system.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can initiate transcription and neuronal differentiation, potentially upregulating KIAA2022 during brain development. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A encourages a transcriptionally active chromatin state, which may stimulate KIAA2022 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound can cause DNA demethylation, which may lead to the increased expression of neuronal genes including KIAA2022 by allowing transcription factor binding. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, potentially stimulating the transcription of genes like KIAA2022 via cAMP response elements. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol binds to estrogen receptors and may upregulate gene expression, potentially promoting the transcription of KIAA2022 in estrogen-responsive neural tissues. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can inhibit GSK-3, leading to the activation of Wnt signaling and possibly stimulating the expression of genes involved in neurodevelopment like KIAA2022. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, through HDAC inhibition, can enhance histone acetylation, potentially leading to the upregulation of genes including KIAA2022. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, another HDAC inhibitor, may increase histone acetylation and thus stimulate the expression of developmental genes such as KIAA2022. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate has polyphenolic properties that may interact with various cellular pathways to stimulate the transcription of certain genes, possibly including KIAA2022. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, through glucocorticoid receptor interaction, may induce transcriptional activation of certain genes, potentially including KIAA2022 in specific contexts. | ||||||